These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31638294)

  • 1. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.
    Yanes-Lane M; Dussault C; Linthwaite B; Cox J; Klein MB; Sebastiani G; Lebouché B; Kronfli N
    J Viral Hepat; 2020 Feb; 27(2):205-220. PubMed ID: 31638294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.
    Kronfli N; Mambro A; Riback LR; Ortiz-Paredes D; Dussault C; Chalifoux S; Del Balso L; Petropoulos A; Lim M; Halavrezos A; Sebastiani G; Klein MB; Lebouche B; Cox J; Akiyama MJ
    Int J Drug Policy; 2024 Nov; 133():104624. PubMed ID: 39426103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.
    Kronfli N; Linthwaite B; Kouyoumdjian F; Klein MB; Lebouché B; Sebastiani G; Cox J
    Int J Drug Policy; 2018 Jul; 57():95-103. PubMed ID: 29715590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.
    Crowley D; Van Hout MC; Lambert JS; Kelly E; Murphy C; Cullen W
    Harm Reduct J; 2018 Dec; 15(1):62. PubMed ID: 30538000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
    Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
    BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and provider perspectives inform an intervention to improve linkage to care for HIV patients in Ukraine.
    Kiriazova T; Postnov O; Bingham T; Myers J; Flanigan T; Vitek C; Neduzhko O
    BMC Health Serv Res; 2018 Jan; 18(1):58. PubMed ID: 29378581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding factors influencing linkage to HIV care in a rural setting, Mbeya, Tanzania: qualitative findings of a mixed methods study.
    Sanga ES; Mukumbang FC; Mushi AK; Lerebo W; Zarowsky C
    BMC Public Health; 2019 Apr; 19(1):383. PubMed ID: 30953503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd).
    Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR
    Int J Drug Policy; 2024 Jul; 129():104461. PubMed ID: 38971019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis.
    Amoako A; Ortiz-Paredes D; Engler K; Lebouché B; Klein MB
    Int J Drug Policy; 2021 Oct; 96():103247. PubMed ID: 33853727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison.
    Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C;
    J Viral Hepat; 2018 Dec; 25(12):1526-1532. PubMed ID: 30141261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors.
    Harris M; Rhodes T
    Harm Reduct J; 2013 May; 10():7. PubMed ID: 23651646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying common barriers and facilitators to linkage and retention in chronic disease care in western Kenya.
    Rachlis B; Naanyu V; Wachira J; Genberg B; Koech B; Kamene R; Akinyi J; Braitstein P
    BMC Public Health; 2016 Aug; 16():741. PubMed ID: 27503191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrollment in outpatient care among newly released prison inmates with HIV infection.
    Baillargeon JG; Giordano TP; Harzke AJ; Baillargeon G; Rich JD; Paar DP
    Public Health Rep; 2010; 125 Suppl 1(Suppl 1):64-71. PubMed ID: 20408389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community-A summary scoping review.
    McKeever A; O'Donovan D; Kee F
    J Viral Hepat; 2023 Apr; 30(4):278-282. PubMed ID: 36636765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving HIV Care Engagement in the South from the Patient and Provider Perspective: The Role of Stigma, Social Support, and Shared Decision-Making.
    Taylor BS; Fornos L; Tarbutton J; Muñoz J; Saber JA; Bullock D; Villarreal R; Nijhawan AE
    AIDS Patient Care STDS; 2018 Sep; 32(9):368-378. PubMed ID: 30179530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health System Features That Enhance Access to Comprehensive Primary Care for Women Living with HIV in High-Income Settings: A Systematic Mixed Studies Review.
    O'Brien N; Hong QN; Law S; Massoud S; Carter A; Kaida A; Loutfy M; Cox J; Andersson N; de Pokomandy A
    AIDS Patient Care STDS; 2018 Apr; 32(4):129-148. PubMed ID: 29630850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV risk after release from prison: a qualitative study of former inmates.
    Adams J; Nowels C; Corsi K; Long J; Steiner JF; Binswanger IA
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):429-34. PubMed ID: 21522015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitions to Care in the Community for Prison Releasees with HIV: a Qualitative Study of Facilitators and Challenges in Two States.
    Hammett TM; Donahue S; LeRoy L; Montague BT; Rosen DL; Solomon L; Costa M; Wohl D; Rich JD
    J Urban Health; 2015 Aug; 92(4):650-66. PubMed ID: 26022666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.